« Back to the previous page

Also available in:

Buyer for sterile pharmaceutical manufacturer in Europe

Company to buy

  • Size: small and medium-sized business
  • Revenue: 2-40 M EUR
  • Location of the target company: Europe and US. 
  • Reason for acquisition: The company wants a sterile manufacturing, Filling, Packaging and distribution to launch a new project. 
  • #CFIE PHB066

Overview of this buyer for a pharmacovigilance supplier Europe unit wanted 

This buyer is looking for a new acquisition worldwide. The company is interested to acquire pharmaceutical sterile manufacturing or filling to ramp up production capacity for production of new products. The company should have a sterile area with utilities, that is what the buyer is specifically looking for.

Profile (strategy) of pharmaceutical manufacturing buyer

A company with more than 500 employees with a presence in more than 19 countries. Focusing on immunology business, the firm research and development allergy treatments. They have presence in Europe and US market and their products include both injectable and sublingual (oral) vaccines for grass, tree and house dust mite. Besides that, there are other vaccines in pre-clinical development. The company holds international manufacturing approvals from regulatory agencies the United States Food and Drug Administration and the Europe Union. Their products are already marketed in the USA, Germany, Netherlands, Austria, UK, Spain, Italy, Switzerland and others.

The company’s main pharma products are:

  • Pollinex
  • Pollinex Quattro
  • Oralvac
  • Acarovac Plus
  • Venomil

Buyer of pharmaceutical packaging company

Contact us to get details about this buyer of pharmaceutical packaging company

Activities and products of the target pharmaceutical manufacturing unit

The buyer is now looking for a company with products that provide sterile manufacturing or filling. 

The goal of the buyer is to acquire a profitable manufacturing pharma company with EBITDA in the range of 1 – 5 million euro.

Highlights of the pharmaceutical manufacturing buyer

  • A specialist allergy treatment company with a good M&A activities. 
  • Presence in more than 19 countries including EU and the USA. 
  • Company’s products include both injectable and sublingual (oral) vaccines for grass, tree and house dust mite.  

Information about this buyer of pharmaceutical manufacturing firm 

Feel free to contact us for more information regarding this pharmaceutical manufacturing firm wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical  manufacturing units, please visit the section pharmaceutical companies wanted. For pharmaceutical manufacturing firm for sale visit the section pharmaceutical companies for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.